Wound Management

Diabetic Foot Ulcer Health Economics

Adtec Healthcare Limited has invested over 10 years in clinical trials and studies to bring you over 80+ peer reviewed studies to validate why the SteriPlas Premium Cold Plasma is the leading medical device in the medical industry for chronic infection management. Not only is our medical device clearly proven to be the strongest against multi-resistant bacteria protected within biofilm but it can treat a wide variety of deep and hard to reach areas that are often recalcitrant to conventional therapies, therefore not limited to superficial wound treatments.

Our recent goal has been to collect the cost effectiveness findings to demonstrate just how the cost burden can be eliminated by the hospital when using our SteriPlas. In the case of chronic diabetic foot ulcers with biofilm presence in the NHS, the SteriPlas has been shown to reduce antibiotic usage by 57% for patients thus relieving the ongoing costs thrown onto the hospital service. Not only are patients healed significantly faster, bed occupancy significantly reduced, and limbs are saved but there is a significant reduction in patient visits to the hospitals thus relieving further costs associated to the hospital.

For more information about our Health Economics data, contact us at info@adtecplasma.com

by Adtec Healthcare

Is all Cold Plasma created equal?

There is no doubt a wide variety of Cold Plasma medical devices currently on the market and new Cold Plasma designs often being released by startup companies. But how do these devices compare in efficacy, strength, reliability, and performance?

To say all Cold Plasmas are the same, which some companies (shockingly) do, would be farfetched and misleading. This is like comparing a race between a sports car and a bicycle or saying all liquids or gases are the same – the product and plasma components are technically very different.

When Adtec first developed Cold Plasma and carried out the first ever clinical trials on wounds many years ago, our data showed the remarkably strong and reputable results that we still deliver today. This is exclusively for our range of Adtec Cold Plasma medical devices. Our data is often cited by other Cold Plasma companies as their own medical devices lack strength in efficacy and performance in clinical data.

The important questions to raise are:
- What is the frequency of Cold Plasma applications per week to achieve full healing?
- How deep can the Cold Plasma penetrate?
- How quick can the Cold Plasma be applied?
- What is the delivery method of Cold Plasma?
- Is Cold Plasma limited to acute and superficial wounds or can it treat deep, chronic wounds with biofilm?
- What is the clinical evidence for the product itself and not cold plasma in general?

Whilst there are some Cold Plasma medical devices that do not satisfy the requirements met by a wound clinician, the SteriPlas does remain the leader and favorable choice in the Cold Plasma medical market. A once per week treatment time of 2 minutes per 12cm2 has been shown to accelerate healing in chronic, problematic, and non-healing wounds with biofilm presence. This cannot be said for all other Cold Plasma devices which recommend treatment once per day and are only indicated for acute, small, and superficial wounds certainly with no biofilm presence.

Due to its overall larger size which houses crucial components ensuring a consistent, reliable and therapeutic Cold Plasma, the SteriPlas is the only microwave-energy, Cold Argon Plasma medical device which delivers deep, dense and rich Cold Plasma able to kill all bacterial species embedded within biofilm. We can boast that no side effects have been reported with our Cold Plasma medical device since the history of its making.

For more information about the SteriPlas and how we have changed the way that wounds are healed, please visit our page: https://adtechealthcare.com/cold-plasma-wound-treatment/

by Adtec Healthcare